CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling

被引:0
|
作者
Langstein, J
Michel, J
Fritsche, J
Kreutz, M
Andreesen, R
Schwarz, H [1 ]
机构
[1] Univ Regensburg, Dept Pathol, D-93042 Regensburg, Germany
[2] Univ Regensburg, Dept Hematol, D-93042 Regensburg, Germany
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 160卷 / 05期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD137 (ILA/4-1BB), a member of the TNF receptor family, was shown previously to inhibit proliferation and to induce apoptosis in T lymphocytes. In this study, we identify CD137 as a novel and potent monocyte activation factor, CD137 protein induces expression of IL-6, IL-8, and TNF-alpha, and inhibits expression of IL-10. Furthermore, CD137 differentially regulates expression of cell surface receptors, It induces expression of ICAM and reduces expression of Fc gamma RIII, while levels: of HLA-DR remain unchanged. CD137 also promotes adherence of monocytes. These effects of CD137 require immobilization of CD137 protein, indicating that they are mediated by cross-linking of a corresponding ligand/coreceptor expressed on monocytes.
引用
收藏
页码:2488 / 2494
页数:7
相关论文
共 50 条
  • [1] CD137, a member of the TNF receptor family regulates monocyte activation and survival via reverse signaling
    Langstein, J
    Michel, J
    Fritsche, J
    Kreutz, M
    Andreesen, R
    Schwartz, H
    CANCER GENE THERAPY, 1997, 4 (06) : P160 - P160
  • [2] CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes
    Kienzle, G
    von Kempis, J
    INTERNATIONAL IMMUNOLOGY, 2000, 12 (01) : 73 - 82
  • [3] Tumor cells express the ligand for the tumor necrosis factor receptor family member 4-1BB (CD137/ILA)
    Salih, H
    Loo, D
    Stetsko, D
    Kosowski, S
    Aruffo, A
    Kiener, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S13 - S13
  • [4] A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis
    Michel, J
    Langstein, J
    Hofstadter, F
    Schwarz, H
    CANCER GENE THERAPY, 1997, 4 (06) : P161 - P161
  • [5] A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis
    Michel, J
    Langstein, J
    Hofstädter, F
    Schwarz, H
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (01) : 290 - 295
  • [6] Engagement of CD137 (ILA/human 4-1BB) on activated human monocytes induces the production of cytokines.
    von Kempis, J
    Kienzle, G
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S142 - S142
  • [7] Expression and regulation of ILA (human 4-1BB/CD137) in B cell lines
    vonKempis, J
    Kienzle, G
    Braun, M
    Illges, H
    Peter, HH
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 55 - 55
  • [8] 4-1BB (CD137) in anticancer chimeras
    Melero, Ignacio
    Berraondo, Pedro
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (12):
  • [9] Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB)
    Azpilikueta, Arantza
    Bolanos, Elixabet
    Lang, Valerie
    Labiano, Sara
    Aznar, Maria A.
    Etxeberria, Inaki
    Teijeira, Alvaro
    Rodriguez-Ruiz, Maria E.
    Perez-Gracia, Jose L.
    Jure-Kunkel, Maria
    Zapata, Juan M.
    Rodriguez, Manuel S.
    Melero, Ignacio
    ONCOIMMUNOLOGY, 2018, 7 (01):
  • [10] The therapeutic potential of 4-1BB (CD137) in cancer
    Nam, KO
    Kang, WJ
    Kwon, BS
    Kim, SJ
    Lee, HW
    CURRENT CANCER DRUG TARGETS, 2005, 5 (05) : 357 - 363